BellC. E., and SomervilleA. R.: Identity of the ‘pink spot’.Nature,211: 1405–1406, 1966.
2.
ErnstA. M.: Phenomena of the hypokinetic rigid type caused by O-methylation of dopamine in the para-position.Nature,193: 178–179, 1962.
3.
ErnstA. M.: Relation between the structure of certain methoxyphenylethylamine derivatives and the occurrence of a hypokinetic rigid syndrome.Psychopharmacologia,7: 383–390, 1965.
4.
FriedhoffA. J., and Van WinkleE.: Isolation and characterization of a compound from the urine of schizophrenics.Nature,194: 897–898, 1962.
5.
HollisterL. E., and FriedhoffA. J.: Effects of 3,4-dimethoxyphenylethylamine in man.Nature,210: 1377–1378, 1966.
6.
MichauxR., and VerlyW. G.: Action catalepsigene des ethers methyliques des mon- et polyphenolamines.Life Sci., No. 3, 175–183, 1963.
7.
PerryT. L., HansenS., and MacDougallL.: Identity and significance of some pink spots in schizophrenia and other conditions.Nature,214: 484–485, 1967.
8.
SenN. P., and McGeerP. L.: 4-Methoxy-phenylethylamine and 3,4-dimethoxyphenylethylamine in human urine.Biochem. Biophys. Res. Commun.,14: 227–232, 1964.
9.
ShulginA. T., ThorntonS., and NaranjoC.: Role of 3,4-dimethoxyphenethylamine in schizophrenia.Nature,212: 1606–1607, 1966.